Pharm prime vendor fleet

This delivery order (Contract 4570324077) valued at $3,548.95 was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, issued on December 8, 2025, is structured as a firm fixed-price delivery order under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent IDC, awarded on November 13, 2025, carries a $499.99 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract requires no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement.

Under this delivery order structure, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare operations worldwide, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs. The vendor's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals supporting recurring medical supply needs across federal healthcare facilities. Performance location for this delivery order is established in Park Ridge, Illinois, with an ultimate completion date of December 30, 2025. The company's consistent award activity through the Defense Logistics Agency's Medical Supply Chain division throughout 2025 demonstrates established operational capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.